International Clinical Trial: Establishment and verification of the risk prediction model of thrombocytopenia caused by pyracilintazobam in elderly patients

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131349) titled 'Establishment and verification of the risk prediction model of thrombocytopenia caused by pyracilintazobam in elderly patients' on Sept. 1.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Department of Pharmacy, Xiangya Hospital, Central South University

Condition: Thrombocytopenia

Intervention: The thrombocytopenia group using pyracillintazobam:No

Recruitment Status: Not Recruiting

Phase: Retrospective study

Date of First Enrollment: 2025-04-04

Target Sample Size: The thrombocytopenia group using pyracillintazobam:80;Non-thrombocytopenia group using piracillintazobam:40...